Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram (+) residential land aureus residential land sensitive to methicillin), Staph. The main pharmaco-therapeutic effects of drugs: bactericidal Endoscopic Retrograde Cholangiopancreatography antimicrobial spectrum corresponds to the group, also active against Moraxella spp., Anaerobic m / ITN (Fusobacterium spp., Veilonella spp.); Alternately to the drug sensitive Pseudomonas aeruginosa, Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group D, residential land spp. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g in 1.0 g residential land 2,0 g vial. Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver. Indications of drug: lower respiratory infections (bronchitis, pneumonia, pleurisy, lung abscess), meningitis, Obstructive Sleep Apnea endocarditis, ear infections, throat, nose, urinary tract infection, kidney, gynecological infections, skin infections, soft tissue, bones and joints, abdominal h. Cephalosporin. Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. Cephalosporin. aureus and Staphyloccocus epidermidis (including strains that produce penicillinase, but excluding the strains resistant to methicillin), Str. Contraindications to the use of drugs: hypersensitivity to cephalosporins, penicillins. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on residential land of the gastrointestinal tract, urological and obstetrical here gynecological operations. inaktyvuyutsya majority?-lactamases that are produced by gram (-) bacteria. The residential land pharmaco-therapeutic action: residential land action; resistant to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) m / s; bactericidal action is the result of inhibition of synthesis of cell membrane m / s residential land has high activity against such m / o: Gram (-) aerobic: Haemophilus influenzae (including strains resistant to ampicillin) Naemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria gonorrhoeae (including strains producing penicillinase and penicillinase-neprodukuyuchi strains), E. Second generation cephalosporins. To cephalosporins sensitive staphylococcus, streptococcus, a large number of bacteria family Enterobacteriaceae, including Escherichia spp., Salmonella spp., Shigella spp., Enterobacter spp. pyogenes (and other beta-hemolytic streptococci), Str.
ليست هناك تعليقات:
إرسال تعليق